NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
31-45 of 365
Who’s Missing from Multiple Sclerosis Research?
NeuroFrontiersWho’s Missing from Multiple Sclerosis Research?
Ashley Baker, MSN, PMHNP
Ruth Ann Marrie, MD, PhD
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
NeuroFrontiersGFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
NeuroFrontiersAdvancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Adil Harroud, MD
Dylan Hamitouche
Ryan Quigley
Understanding Accelerated Biological Aging in Pediatric MS
NeuroFrontiersUnderstanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
NeuroFrontiersMultiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
- advertisement
Multiple Sclerosis Without Borders: Taking a Global View
NeuroFrontiersMultiple Sclerosis Without Borders: Taking a Global View
Andrew Wilner, MD, FACP, FAAN
Victor Rivera, MD
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiersIron Deposition and Cognitive Fatigue in Multiple Sclerosis
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
NeuroFrontiersVitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiersOptimizing Vitamin D Supplementation in MS Care
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiersThe Role of Neurofilament Light Chain in MS Management
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiersAddressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS
Michael Halassa, MD, PhD
- advertisement
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiersHow Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiersParkinson’s Research in Focus: Translating Science Into Clinical Progress
Jerome Lisk, MD, MBA, M.S., FAAN
Michael Salvatore, PhD
Vicki Nejtek-Salvatore, PhD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiersDetecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
